0001236031-20-000011.txt : 20200227 0001236031-20-000011.hdr.sgml : 20200227 20200227075725 ACCESSION NUMBER: 0001236031-20-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200226 FILED AS OF DATE: 20200227 DATE AS OF CHANGE: 20200227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watson Robert Eugene CENTRAL INDEX KEY: 0001511858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 20658529 MAIL ADDRESS: STREET 1: 245 N. HIGHLAND AVE NE STREET 2: SUITE 230-296 CITY: ATLANTA STATE: 2Q ZIP: 30307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-02-26 0 0000725363 CEL SCI CORP CVM 0001511858 Watson Robert Eugene 245 N. HIGHLAND AVE NE SUITE 230-296 ATLANTA 2Q 30307 GEORGIA 1 0 0 0 Common Stock 2020-02-26 4 P 0 923 10.83 A 2381 D On February 26, 2020, Mr. Watson purchased $10,000 worth of restricted stock directly from the Company at the closing price on February 26, 2020, the most recent closing price available. Robert Watson 2020-02-27